Interestingly, BHLHE40 stimulates TRM (tissue-resident memory CD8+ T) and TIL (tumor-infiltrating lymphocyte) cell proliferation and functionality (Figure 3) [45]; however, the excessive accumulation of TRM cells is not protective but, rather, drives inflammatory and fibrotic sequelae after primary respiratory viral infection [46]. Here, CD8A is linked to neoplasm.